Details for: DIPRIVAN EML IV 1%
Company: ASPEN PHARMACARE CANADA INC.
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02018950 | DIPRIVAN 1% | PROPOFOL | 10 MG / ML | EMULSION | INTRAVENOUS |
Summary Reports
Summary Safety Review - Sedative and anesthetic drugs (DIPRIVAN [propofol], KETALAR [ketamine], SEVORANE [sevoflurane], SUPRANE [desflurane], FORANE/ISOFLURANE USP [isoflurane] - Assessing the potential risk of negative effects on the development of children's brains (neurodevelopmental disorders)
Summary Safety Review - Propofol-containing products - Assessing the potential risk of prolonged erection of the penis (priapism)
Summary Safety Review - Propofol-containing products - Assessing the potential risk of prolonged erection of the penis (priapism)
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.